• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: KANEKA CORPORATION KANEKA PTCA CATHETER CO-R8 (TASUKI)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

KANEKA CORPORATION KANEKA PTCA CATHETER CO-R8 (TASUKI) Back to Search Results
Catalog Number TS-16-200
Device Problem Material Fragmentation (1261)
Patient Problems Device Embedded In Tissue or Plaque (3165); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/26/2020
Event Type  Injury  
Manufacturer Narrative
The concerned device subject to this reported event, "tasuki", an rx-type ptca balloon catheter compatible with 0.014" guidewire (gw), is not distributed in the us, however, we intend to report this case as the event occurred on one of the similar devices for "rx takeru ptca balloon dilatation catheter" distributed in the us under 510(k) # k163372.The device history records (dhr) of the device concerned was reviewed: the production lot, to which the device concerned belongs, passed all in-process inspections including the shaft-pressurized test and the balloon-wrapping test for every product, and the finished product inspections including the shaft tensile strength test and the repetitive balloon inflation/deflation test on representative samples based on sampling plan.No nonconformity or abnormality in the manufacturing processes of the device concerned was found.Results of the investigation on returned concerned device: during use, a balloon was dilated 14 times with pressure including exceeded rated burst pressure, and ruptured.A part of the balloon and the catheter (distal tip) reached the break by being load of the excessive pulling force in the severe calcified lesion.The length of the residual part inside the patient body was assumed approximately 16mm including distal tip, a radiopaque marker, and balloon.We concluded that the incident is determined not to be caused by any defect of the device, but to be caused by procedure/user.
 
Event Description
Tasuki was inserted into the severe calcified lesion and was dilated 14 times with pressure including exceeded rated burst pressure.While withdrawing the catheter, the physician felt some difficulty and resistance due to the severe calcification.The distal tip and a part of balloon could not be removed from the lcx lesion.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
KANEKA PTCA CATHETER CO-R8 (TASUKI)
Type of Device
TASUKI
Manufacturer (Section D)
KANEKA CORPORATION
2-3-18
nakanoshima, kita-ku
osaka-city, 530-8 288
JA  530-8288
Manufacturer (Section G)
KANEKA CORPORATION OSAKA PLANT
5-1-1
torikai-nishi
settsu-city, osaka 566-0 072
JA   566-0072
Manufacturer Contact
joji sengoku
1-12-32
akasaka
minato-ku, tokyo 107-6-028
JA   107-6028
MDR Report Key10999736
MDR Text Key221233076
Report Number3002808904-2020-00022
Device Sequence Number1
Product Code LOX
Combination Product (y/n)N
Reporter Country CodeJA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Reporter Occupation Physician
Type of Report Initial
Report Date 11/26/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/13/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/30/2021
Device Catalogue NumberTS-16-200
Device Lot NumberSP128011
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/01/2020
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/26/2020
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured12/11/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-